Neurocardiogenic syncope epidemiology and demographics

Jump to navigation Jump to search

WikiDoc Resources for Neurocardiogenic syncope epidemiology and demographics

Articles

Most recent articles on Neurocardiogenic syncope epidemiology and demographics

Most cited articles on Neurocardiogenic syncope epidemiology and demographics

Review articles on Neurocardiogenic syncope epidemiology and demographics

Articles on Neurocardiogenic syncope epidemiology and demographics in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Neurocardiogenic syncope epidemiology and demographics

Images of Neurocardiogenic syncope epidemiology and demographics

Photos of Neurocardiogenic syncope epidemiology and demographics

Podcasts & MP3s on Neurocardiogenic syncope epidemiology and demographics

Videos on Neurocardiogenic syncope epidemiology and demographics

Evidence Based Medicine

Cochrane Collaboration on Neurocardiogenic syncope epidemiology and demographics

Bandolier on Neurocardiogenic syncope epidemiology and demographics

TRIP on Neurocardiogenic syncope epidemiology and demographics

Clinical Trials

Ongoing Trials on Neurocardiogenic syncope epidemiology and demographics at Clinical Trials.gov

Trial results on Neurocardiogenic syncope epidemiology and demographics

Clinical Trials on Neurocardiogenic syncope epidemiology and demographics at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Neurocardiogenic syncope epidemiology and demographics

NICE Guidance on Neurocardiogenic syncope epidemiology and demographics

NHS PRODIGY Guidance

FDA on Neurocardiogenic syncope epidemiology and demographics

CDC on Neurocardiogenic syncope epidemiology and demographics

Books

Books on Neurocardiogenic syncope epidemiology and demographics

News

Neurocardiogenic syncope epidemiology and demographics in the news

Be alerted to news on Neurocardiogenic syncope epidemiology and demographics

News trends on Neurocardiogenic syncope epidemiology and demographics

Commentary

Blogs on Neurocardiogenic syncope epidemiology and demographics

Definitions

Definitions of Neurocardiogenic syncope epidemiology and demographics

Patient Resources / Community

Patient resources on Neurocardiogenic syncope epidemiology and demographics

Discussion groups on Neurocardiogenic syncope epidemiology and demographics

Patient Handouts on Neurocardiogenic syncope epidemiology and demographics

Directions to Hospitals Treating Neurocardiogenic syncope epidemiology and demographics

Risk calculators and risk factors for Neurocardiogenic syncope epidemiology and demographics

Healthcare Provider Resources

Symptoms of Neurocardiogenic syncope epidemiology and demographics

Causes & Risk Factors for Neurocardiogenic syncope epidemiology and demographics

Diagnostic studies for Neurocardiogenic syncope epidemiology and demographics

Treatment of Neurocardiogenic syncope epidemiology and demographics

Continuing Medical Education (CME)

CME Programs on Neurocardiogenic syncope epidemiology and demographics

International

Neurocardiogenic syncope epidemiology and demographics en Espanol

Neurocardiogenic syncope epidemiology and demographics en Francais

Business

Neurocardiogenic syncope epidemiology and demographics in the Marketplace

Patents on Neurocardiogenic syncope epidemiology and demographics

Experimental / Informatics

List of terms related to Neurocardiogenic syncope epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Neurocardiogenic syncope is the most common cause of syncope in children and adults.

Incidence

The prevalence is 22% in the general population. Approximately 50%-66% of syncope cases are classified as due to vasovagal syncope.